Business & Finance Novartis Inks Chinese mRNA-Therapy Deal for Up to $7.8 Billion
Novartis AG will license a messenger RNA-based autoimmune therapy from China’s Abogen Biosciences, in a deal worth as much as $7.8 billion.
By
· October 2, 2026 · 1 min read
This article was originally published by
Bloomberg Markets
and is republished here under license.
Novartis AG will license a messenger RNA-based autoimmune therapy from China’s Abogen Biosciences, in a deal worth as much as $7.8 billion.
Related
The co-pilot attacked the pilot inside the cockpit with a crash axe and attempted to take control of the aircraft,…
By
· October 3, 2026 · 1 min read
Malaysia’s defense minister said the government is considering spending more than 1 billion ringgit ($245 million) on a new naval…
By
· October 3, 2026 · 1 min read
Investigators probing the near-catastrophic Dubai to Tel Aviv flight said the FlyDubai co-pilot attempted “a terrorist operation” when he assaulted…
By
· October 3, 2026 · 1 min read
Leave a Reply